XML 33 R23.htm IDEA: XBRL DOCUMENT v3.25.3
Shareholders' Equity
 9 Months Ended
Sep. 30, 2025
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders’ Equity
The following table presents the amounts related to each component of OCI:
Three Months Ended September 30,
20252024
PretaxIncome Tax Benefit (Expense)Net of TaxPretaxIncome Tax Benefit (Expense)Net of Tax
(in millions)
Net unrealized gains (losses) on securities:
Net unrealized gains (losses) on securities arising during the period (1)
$479 $(106)$373 $1,312 $(293)$1,019 
Reclassification of net (gains) losses on securities included in net income (2)
(11)2 (9)2 (2)— 
Impact of benefit reserves and reinsurance recoverables(10)3 (7)(18)4 (14)
Net unrealized gains (losses) on securities458 (101)357 1,296 (291)1,005 
Net unrealized gains (losses) on derivatives:
Reclassification of net (gains) losses on derivatives included in net income (3)
— — — (1)1 — 
Net unrealized gains (losses) on derivatives— — — (1)1 — 
Effect of changes in discount rate assumptions on certain long-duration contracts(58)12 (46)(188)41 (147)
Effect of changes in instrument-specific credit risk on MRBs(13)3 (10)(63)14 (49)
Foreign currency translation(35)1 (34)85 (2)83 
Total other comprehensive income (loss)$352 $(85)$267 $1,129 $(237)$892 
Nine Months Ended September 30,
20252024
PretaxIncome Tax Benefit (Expense)Net of TaxPretaxIncome Tax Benefit (Expense)Net of Tax
(in millions)
Net unrealized gains (losses) on securities:
Net unrealized gains (losses) on securities arising during the period (1)
$1,203 $(270)$933 $896 $(203)$693 
Reclassification of net (gains) losses on securities included in net income (2)
(1)— (1)4 (2)2 
Impact of benefit reserves and reinsurance recoverables(12)3 (9)(4)1 (3)
Net unrealized gains (losses) on securities1,190 (267)923 896 (204)692 
Net unrealized gains (losses) on derivatives:
Net unrealized gains (losses) on derivatives arising during the period
(11)2 (9)— — — 
Reclassification of net (gains) losses on derivatives included in net income(3)
— — — (1)1 — 
Net unrealized gains (losses) on derivatives(11)2 (9)(1)1 — 
Effect of changes in discount rate assumptions on certain long-duration contracts(111)23 (88)(21)5 (16)
Effect of changes in instrument-specific credit risk on MRBs(11)3 (8)(98)21 (77)
Foreign currency translation124 (3)121 69 (3)66 
Total other comprehensive income (loss)$1,181 $(242)$939 $845 $(180)$665 
(1) Includes impairments on Available-for-Sale securities related to factors other than credit that were recognized in OCI during the period.
(2) Reclassification amounts are recorded in Net investment income.
(3) Includes a nil and $1 million pretax gain reclassified to Interest and debt expense.
Other comprehensive income (loss) related to net unrealized gains (losses) on securities includes three components: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit losses to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates.
The following table presents the changes in the balances of each component of AOCI, net of tax:
Net Unrealized Gains (Losses)
on Securities		Net Unrealized Gains (Losses)
on Derivatives		Effect of Changes in Discount Rate Assumptions on Certain Long-Duration ContractsEffect of Changes in Instrument-Specific Credit Risk on MRBsDefined
Benefit Plans		Foreign Currency TranslationOtherTotal
(in millions)
Balance at July 1, 2025
$(886)$(4)$(15)$(145)$(45)$(140)$(1)$(1,236)
OCI before reclassifications366—(46)(10)—(34)—276
Amounts reclassified from AOCI(9)——————(9)
Total OCI357—(46)(10)—(34)—267
Balance at September 30, 2025
$(529)$(4)$(61)$(155)$(45)$(174)$(1)$(969)
Balance at July 1, 2024
$(1,554)$5$5$(113)$(60)$(275)$(1)$(1,993)
OCI before reclassifications1,005—(147)(49)—83—892
Amounts reclassified from AOCI————————
Total OCI1,005—(147)(49)—83—892
Balance at September 30, 2024
$(549)$5$(142)$(162)$(60)$(192)$(1)$(1,101)
Balance at January 1, 2025
$(1,452)$5$27$(147)$(45)$(295)$(1)$(1,908)
OCI before reclassifications924(9)(88)(8)—121—940
Amounts reclassified from AOCI(1)——————(1)
Total OCI923(9)(88)(8)—121—939
Balance at September 30, 2025
$(529)$(4)$(61)$(155)$(45)$(174)$(1)$(969)
Balance at January 1, 2024
$(1,241)$5$(126)$(85)$(60)$(258)$(1)$(1,766)
OCI before reclassifications690—(16)(77)—66—663
Amounts reclassified from AOCI2——————2
Total OCI692—(16)(77)—66—665
Balance at September 30, 2024
$(549)$5$(142)$(162)$(60)$(192)$(1)$(1,101)
For the nine months ended September 30, 2025 and 2024, the Company repurchased a total of 3.7 million shares and 3.8 million shares, respectively, of its common stock for an aggregate cost of $1.9 billion and $1.6 billion, respectively. On July 24, 2023, the Company’s Board of Directors authorized $3.5 billion for the repurchase of the Company’s common stock through September 30, 2025, which was exhausted during the second quarter of 2025. On April 22, 2025, the Company’s Board of Directors authorized $4.5 billion for the repurchase of the Company’s common stock through June 30, 2027. As of September 30, 2025, the Company had $3.5 billion remaining under this share repurchase authorization.

The Company may also reacquire shares of its common stock under its share-based compensation plans related to restricted stock awards and certain option exercises. The holders of restricted shares may elect to surrender a portion of their shares on the vesting date to cover their income tax obligation. These vested restricted shares are reacquired by the Company and the Company’s payment of the holders’ income tax obligations are recorded as a treasury share purchase.
For the nine months ended September 30, 2025 and 2024, the Company reacquired 0.2 million and 0.3 million shares, respectively, of its common stock through the surrender of shares upon vesting and paid in the aggregate $132 million and $110 million, respectively, related to the holders’ income tax obligations on the vesting date. Option holders may elect to net settle their vested awards resulting in the surrender of the number of shares required to cover the strike price and tax obligation of the options exercised. These shares are reacquired by the Company and recorded as treasury shares. For the nine months ended September 30, 2025 and 2024, the Company
reacquired 0.1 million shares and 0.4 million shares, respectively, of its common stock through the net settlement of options for an aggregate value of $66 million and $149 million, respectively.
During both the nine months ended September 30, 2025 and 2024, the Company reissued 0.7 million treasury shares for restricted stock award grants, performance share units and issuance of shares vested under advisor deferred compensation plans.